Skip to main content
Livermore
Livermore
ZHEN

Evommune, Inc.

EVMN
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0002044725

In the last 90 days, Evommune, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $462.5M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Evommune, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of EVMN: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders843105+24
Shares34.6M2.18M34.6M+2.19M (+6.7%)
Value$793.4M$50.1M$462.5M−$280.8M (−37.8%)

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (41)

Institutions that held Evommune, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to EVMN in Q2 2026
InstitutionSharesValue% of portfolio
Vestal Point Capital, LP1,000,000$13.3M0.31%
Jupiter Topco LLC896,700$11.9M0.00%
Balyasny Asset Management LLC457,015$6.07M0.01%
Jane Street Group, LLC232,440$3.09M0.00%
OrbiMed Advisors LLC161,000$2.14M0.04%
LMR Partners LLP118,436$1.57M0.01%
Longaeva Partners L.P.116,611$1.55M0.04%
Holocene Advisors, LP111,132$1.48M0.00%
Avidity Partners Management LP75,000$996.8K0.16%
Quadrature Capital Ltd69,311$921.1K0.01%
Cantor Fitzgerald, L. P.51,796$688.4K0.01%
Squarepoint Ops LLC47,702$634.0K0.00%
Alps Advisors Inc36,558$485.9K0.00%
Caption Management, LLC30,581$406.4K0.01%
Jump Financial, LLC30,200$401.4K0.00%
Qube Research & Technologies Ltd30,115$400.2K0.00%
Y-Intercept (Hong Kong) Ltd28,398$377.4K0.01%
Alliancebernstein L.P.15,760$362.3K0.00%
Two Sigma Investments, LP25,526$339.2K0.00%
J. Safra Sarasin Holding AG24,217$321.8K0.00%
Cinctive Capital Management LP23,558$313.1K0.01%
Swiss National Bank21,700$288.4K0.00%
Virtus Investment Advisers, Inc.16,500$219.3K0.05%
Susquehanna International Group, LLP13,184$175.2K0.00%
Deutsche Bank AG12,611$167.6K0.00%
Citadel Advisors LLC10,724$142.5K0.00%
Vanguard Asset Management, Ltd8,006$106.4K0.00%
Quantbot Technologies LP7,640$101.5K0.00%
Los Angeles Capital Management LLC6,685$88.8K0.00%
Natixis5,044$69.4K0.00%
KLP Kapitalforvaltning AS2,400$31.9K0.00%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.1,800$23.9K0.00%
State of Wyoming838$11.1K0.00%
Royal Bank of Canada692$9.00K0.00%
Caitong International Asset Management Co., Ltd289$3.84K0.00%
The PNC Financial Services Group, Inc.92$1.22K0.00%
Quarry LP65$8640.00%
Nisa Investment Advisors, LLC29$3850.00%
GAMMA Investing LLC24$3190.00%
Allworth Financial LP2$270.00%
SRS Capital Advisors, Inc.1$130.00%

Sold out (17)

Institutions that held Evommune, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of EVMN in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
MPM Oncology Impact Management LP1,455,863$33.5M
Marshall Wace, LLP879,728$20.2M
Kynam Capital Management, LP625,496$14.4M
Sectoral Asset Management Inc589,005$13.5M
Perceptive Advisors LLC448,350$10.3M
E Fund Management Co., Ltd.243,700$5.60M
Integral Health Asset Management, LLC225,000$5.17M
StemPoint Capital LP193,777$4.39M
Monashee Investment Management LLC179,340$4.12M
Octagon Capital Advisors LP143,472$3.30M
Propel Bio Management, LLC55,664$1.28M
Hudson Bay Capital Management LP51,364$1.18M
Palumbo Wealth Management LLC29,931$688.1K
China Universal Asset Management Co., Ltd.5,000$115.0K
National Bank of Canada2,400$55.0K
STRS Ohio1,800$41.4K
Plante Moran Financial Advisors, LLC1,147$26.4K

Not filed for Q2 2026 yet (3)

Institutions that held Evommune, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EVMN in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
SymBiosis Capital Partners, LLC1,280,778$29.4M
Janus Henderson Group PLC896,700$20.6M
CWM, LLC7$161